DK1074266T3 - Levende svækkede bakterier til anvendelse i vaccine - Google Patents

Levende svækkede bakterier til anvendelse i vaccine

Info

Publication number
DK1074266T3
DK1074266T3 DK00201985T DK00201985T DK1074266T3 DK 1074266 T3 DK1074266 T3 DK 1074266T3 DK 00201985 T DK00201985 T DK 00201985T DK 00201985 T DK00201985 T DK 00201985T DK 1074266 T3 DK1074266 T3 DK 1074266T3
Authority
DK
Denmark
Prior art keywords
live attenuated
relates
vaccine
bacteria
attenuated bacteria
Prior art date
Application number
DK00201985T
Other languages
English (en)
Inventor
Petrus Johannes Maria Nuijten
Paul S Cohen
David C Laux
Original Assignee
Intervet Int Bv
Rhode Island Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv, Rhode Island Education filed Critical Intervet Int Bv
Application granted granted Critical
Publication of DK1074266T3 publication Critical patent/DK1074266T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DK00201985T 1999-06-09 2000-06-06 Levende svækkede bakterier til anvendelse i vaccine DK1074266T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/328,859 US6764687B1 (en) 1999-06-09 1999-06-09 Live attenuated bacteria for use in a vaccine

Publications (1)

Publication Number Publication Date
DK1074266T3 true DK1074266T3 (da) 2007-04-10

Family

ID=23282768

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00201985T DK1074266T3 (da) 1999-06-09 2000-06-06 Levende svækkede bakterier til anvendelse i vaccine

Country Status (17)

Country Link
US (1) US6764687B1 (da)
EP (1) EP1074266B1 (da)
JP (1) JP4716542B2 (da)
KR (1) KR100602460B1 (da)
AT (1) ATE347905T1 (da)
AU (1) AU779795B2 (da)
BR (1) BR0002602A (da)
CA (1) CA2308691A1 (da)
CY (1) CY1107560T1 (da)
DE (1) DE60032293T2 (da)
DK (1) DK1074266T3 (da)
ES (1) ES2276662T3 (da)
HU (1) HUP0002228A3 (da)
MX (1) MXPA00005734A (da)
NZ (1) NZ505018A (da)
PT (1) PT1074266E (da)
ZA (1) ZA200002615B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7468269B2 (en) * 2003-02-26 2008-12-23 University Of Massachusetts Reagents for recombinogenic engineering and uses thereof
ATE495757T1 (de) * 2003-08-29 2011-02-15 Rhode Island Education Attenuierte bakterielle lebendvakzine
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
RU2561673C2 (ru) * 2006-03-30 2015-08-27 Эмбрекс, Инк. Способы и композиции для вакцинации домашней птицы
KR101491793B1 (ko) 2013-09-10 2015-02-16 대한민국 신규한 액티노바실러스 플로르뉴모니아 혈청형 12번 균주, 이를 포함하는 진단용 조성물 및 백신 조성물
KR101993186B1 (ko) 2018-12-04 2019-06-27 이용근 셔트 타입 연속 포장기

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0284172A (ja) * 1988-07-21 1990-03-26 Smithkline Beckman Corp 異種遺伝子の発現能を有し、組換え型ワクチンとして有用なサルモネラ形質転換体
IT1262895B (it) * 1992-03-02 1996-07-22 Proteina estratta da ceppi citotossici di helicobacter pylori, gene che la esprime, uso della proteina come vaccino o diagnostico.

Also Published As

Publication number Publication date
AU779795B2 (en) 2005-02-10
DE60032293T2 (de) 2007-05-10
BR0002602A (pt) 2001-01-02
EP1074266A2 (en) 2001-02-07
US6764687B1 (en) 2004-07-20
PT1074266E (pt) 2007-02-28
ZA200002615B (en) 2000-12-08
HUP0002228A2 (en) 2002-06-29
AU3935300A (en) 2000-12-14
MXPA00005734A (es) 2002-08-20
NZ505018A (en) 2001-04-27
DE60032293D1 (de) 2007-01-25
HUP0002228A3 (en) 2009-03-30
EP1074266B1 (en) 2006-12-13
KR20010039651A (ko) 2001-05-15
JP4716542B2 (ja) 2011-07-06
EP1074266A3 (en) 2003-03-26
HU0002228D0 (en) 2000-08-28
CY1107560T1 (el) 2013-03-13
KR100602460B1 (ko) 2006-07-19
CA2308691A1 (en) 2000-12-09
ATE347905T1 (de) 2007-01-15
JP2001039890A (ja) 2001-02-13
ES2276662T3 (es) 2007-07-01

Similar Documents

Publication Publication Date Title
ATE549032T1 (de) Adjuvanzverbindungen zur verbesserung von immunreaktionen auf polynukleotid-basierten impfstoffen
ES2181306T3 (es) Vacunas recombinantes que comprenden bacterias atenuadas inmunogenicas que tienen fenotipo rpos positivo.
WO1998056901A3 (en) Live attenuated vaccines
IL168584A (en) West nile virus vaccine
ATE173166T1 (de) Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
CY1107950T1 (el) Νεϊσσεριακες συνθεσεις εμβολιου και μεθοδοι
DE50206472D1 (de) Attenuierte lebendimpfstoffe
GB2386072A (en) Novel vaccine
HU0005010D0 (da)
DK1425038T4 (da) Svækkede bakterier, der er anvendelige i vacciner
WO2002034773A3 (en) Streptococcal genes
ATE413888T1 (de) Salmonella vakzine
CY1107560T1 (el) Ζωντανα εξασθενημενα βακτηρια για χρηση σε εμβολιο
NO20062469L (no) Streptococcus phocae vaksine
WO2009077744A3 (en) Vaccines for brucellosis
FR2809960B1 (fr) Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
DK1660121T3 (da) Levende svækket bakteriel vaccine
WO2001044278A3 (en) Antigen preparations